Studies show berberine activates the G protein-coupled receptor TGR5, which stimulates L-cells to release GLP-1
Are Wegovy and Ozempic the same drug
New retatrutide data raise the ceiling for what next-generation metabolic drugs may eventually achieve, but investigational results should not be confused with an available treatment plan
Koh B, Xiao J, Ng CH, et al
For type 2 diabetes , NICE recommends GLP-1 receptor agonists as second- or third-line therapy when metformin and other oral agents have not achieved adequate glycaemic control, or as an alternative to insulin in certain circumstances
And, while the studies may not be as comprehensive as those of their pharmaceutical counterparts, its likely that the touted benefits of some of these supplements are not exclusively the result of a collective placebo effect